RecruitingNot ApplicableNCT05878912

The Effect of Obesity and Weight Loss in Heart Failure With Preserved Ejection Fraction

The Effects of Obesity and Weight Loss in Heart Failure: Imaging the Obesity Paradox Using Magnetic Resonance Imaging and Spectroscopy - Heart Failure With Preserved Ejection Fraction Substudy


Sponsor

University of Oxford

Enrollment

120 participants

Start Date

Jan 20, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

This study looks at the effects of weight loss in people who have heart failure with preserved ejection fraction (HFpEF) and are overweight or obese. The main questions it aims to answer are whether weight loss in this group of people improves: 1. The heart's shape, how well it pumps blood and how well it uses fuels 2. The person's quality of life and how much they can exercise Participants will attend 2 study visits, separated by 3-6 months. The intervention period takes place in between the 2 study visits. Each study visit will involve measurements including: * Symptom and quality of life questionnaires * Body measurements such as height and weight * Blood tests * Ultrasound scans of the heart (echocardiogram) * Magnetic Resonance Imaging (MRI) scans of the heart * Exercise components during the scans * 6 minute walk test Participants are randomly allocated (in other words, by lottery) to either 'diet' or 'control' groups. The control group will continue standard care. The diet group will be enrolled in a weight loss program supervised by the study team. Participants in the diet group will replace their usual meals with meal replacement products specifically designed to deliver a low calorie diet for weight loss. The products will consist of formula soups, shakes and porridges. This diet would last 8 weeks, followed by a guided period of food reintroduction and maintenance.


Eligibility

Min Age: 18 YearsMax Age: 85 Years

Inclusion Criteria3

  • Heart failure with preserved ejection fraction (HFpEF)
  • Left ventricular ejection fraction (LVEF) =/\> 50%
  • Body Mass Index (BMI) approximately =/\> 27.5 kg/m\^2

Exclusion Criteria5

  • Contraindications to magnetic resonance imaging
  • NYHA class IV
  • Significant valvular, ischemic, infiltrative or other potentially confounding cardiac disease
  • Pregnancy, planned pregnancy or lactating
  • Any other conditions which may potentially compromise the safety or scientific validity of the study

Interventions

OTHERDiet intervention

The diet intervention delivers a weight loss program. The main component is a total diet replacement low energy diet. The intervention includes a gradual food reintroduction phase and maintenance strategies.


Locations(1)

Oxford Centre for Clinical Magnetic Resonance Research, John Radcliffe Hospital

Oxford, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05878912


Related Trials